Keeps vs TeleMed2U
A detailed head-to-head comparison of Keeps and TeleMed2U — pricing, peptides, consultation models, and patient reviews.
At a Glance
RatingNo reviews
Starting PriceN/A
Peptides1
ConsultationHybrid
Lab TestingNo
Shipping3-5 business days
Pros
- Familiar men's health brand
- Bundled convenience
- Async-first workflow
- Streamlined onboarding
Cons
- GLP-1 program is newer
- Compounding regulatory uncertainty
- Men only
- Limited ongoing clinical support
RatingNo reviews
Starting PriceN/A
Peptides2
ConsultationHybrid
Lab TestingNo
Shipping3-5 business days
Pros
- Insurance accepted for consultations
- Established since 2013
- Primary care breadth means GLP-1 treatment is embedded in comprehensive care, not isolated from the rest of your health
- Video consultations with physicians
- Branded GLP-1 prescriptions through primary care are a more straightforward regulatory pathway than compounding
- California regulation and longer track record provide some additional baseline accountability
Cons
- Not a GLP-1-specialist platform
- Branded GLP-1 medications can be expensive without strong insurance coverage; patients without obesity coverage may face high out-of-pocket medication costs
- Requires scheduled video appointments
- Insurance acceptance means billing complexity; not all plans cover telehealth visits or GLP-1 medications equally
- Less marketing visibility than dedicated GLP-1 platforms, which can make it harder to find patient reviews and comparative information
Pros & Cons
Peptide Pricing Comparison
| Peptide | Keeps | TeleMed2U |
|---|---|---|
| Semaglutide | Price unavailable | Price unavailable |
| Tirzepatide | Not offered | Price unavailable |
Frequently Asked Questions
Is Keeps or TeleMed2U better?
Keeps offers 1 peptide and hybrid consultations. TeleMed2U offers 2 peptides and hybrid consultations. The best choice depends on which peptides you need, your budget, and preferred consultation model.
Which is cheaper, Keeps or TeleMed2U?
See the pricing table above for a detailed comparison.